Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Odapipam is a selective and high affinity antagonist of benzazepine dopamine D1 receptor (Kd of 0.18 nM).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 280,000 |
50 mg | 約6-8 週間 | ¥ 365,000 |
100 mg | 約6-8 週間 | ¥ 558,000 |
In vivo | The metabolic pathway of Odapipam in phenobarbital-induced rat liver microsomes has been examined, revealing the formation of five distinct metabolites during its incubation. Analysis of the electron-ionization (EI+) mass spectra identified these metabolites as N-desmethyl-Odapipam, 1-hydroxy-Odapipam, two isomers of 3′-hydroxy-Odapipam, and a dehydrogenated metabolite within the dihydrobenzofuran moiety[1]. |
別名 | NNC 756 |
分子量 | 329.82 |
分子式 | C19H20ClNO2 |
CAS No. | 131796-63-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Odapipam 131796-63-9 GPCR/G Protein Neuroscience Dopamine Receptor NNC756 NNC 756 NNC-756 Inhibitor inhibitor inhibit